Biodesix Inc. (BDSX) Misses Q2 EPS by 12c

Biodesix Inc. (NASDAQ: BDSX) reported Q2 EPS of ($0.41), $0.12 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $11.9 million versus the consensus estimate of $21.14 million.

For earnings history and earnings-related data on Biodesix Inc. (BDSX) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
• KULR Technology Group (KULR) Misses Q2 EPS by 39c